Browsing Tag
US FDA
379 posts
Zydus Lifesciences gets FDA nod for Zinc Sulfate Injection
Zydus Lifesciences Limited has received final approval from the United States Food and Drug Administration (USFDA) for its…
August 25, 2023
FDA greenlights Pfizer’s ABRYSVO vaccine for shielding infants from RSV
The US Food and Drug Administration (FDA) has granted approval to Pfizer Inc.’s ABRYSVO, a bivalent Respiratory Syncytial…
August 23, 2023
Marksans Pharma bags FDA approval for Mucinex bioequivalent tablets
Indian pharmaceutical powerhouse, Marksans Pharma has achieved a significant milestone, securing the coveted US Food and Drug Administration…
August 22, 2023
FDA greenlights BITT’s Phase I trial of BITT2101 for Non-Hodgkin’s lymphomas
Boston Immune Technologies and Therapeutics, Inc. (BITT), a pioneering clinical-stage biotech company, has announced the US Food and…
August 20, 2023
Can-Fite submits pediatric plan to FDA for Piclidenoson in psoriasis treatment
Biotech leader Can-Fite BioPharma, known for its advances in oncology, inflammatory, and liver diseases, has taken a significant…
August 18, 2023
Zydus Lifesciences bags Doxepin Tablets FDA approval for insomnia
Zydus Lifesciences Limited has secured a pivotal nod from the United States Food and Drug Administration (USFDA) for…
August 17, 2023
Glenmark Pharmaceuticals gets FDA approval for generic Protopic Ointment
Glenmark Pharmaceuticals Ltd., a global leader in pharmaceutical research, has secured the final nod from the U.S. Food…
August 17, 2023
FDA greenlights Pfizer’s ELREXFIO for advanced multiple myeloma treatment
Pfizer Inc. has earned accelerated approval from the U.S. Food and Drug Administration (FDA) for its innovative drug,…
August 17, 2023
Aurobindo Pharma’s subsidiary Eugia Pharma gets FDA approval for Icatibant Injection
In a pivotal move bolstering its footprint in the global pharmaceutical landscape, Aurobindo Pharma Limited’s subsidiary, Eugia Pharma…
August 16, 2023
Lupin gains FDA approval for generic Toprol-XL Tablets
Lupin Limited, a dominant player in the global pharmaceutical landscape, announced its triumph in obtaining the coveted approval…
August 16, 2023